Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2013-11-19 AGM Information
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Presentation to Shareholders 26 pages 4.9MB
AGM Information Classification · 95% confidence The document is titled 'AGM PRESENTATION' and dated 20 November 2013, with the CEO presenting. The content includes company overview, strategy, highlights of the past year, and plans for the future, typical of presentations made at Annual General Meetings. There is no detailed financial data or formal report structure that would indicate an Annual Report or Interim Report. The length is substantial (over 12,000 characters), consistent with a detailed presentation rather than a brief announcement. The document explicitly states it is a presentation, and the content aligns with what is typically shared during an AGM. Therefore, the document is best classified as AGM Information (AGM-R).
2013-11-19 English
Results of Meeting 2 pages 107.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 20 November 2013 reporting the results of the 2013 Annual General Meeting (AGM) of Allied Healthcare Group Limited. It includes detailed voting results for each resolution presented at the AGM, such as adoption of the remuneration report, re-election of directors, authority to issue shares and options, and approval of placement facilities. The document references compliance with the Corporations Act and ASX Listing Rules regarding disclosure of AGM voting results. The content is focused on the official announcement of shareholder voting outcomes rather than the AGM materials themselves or the full annual report. The document length is 3082 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2013-11-19 English
Allied makes first sale of CardioCel into Europe 2 pages 183.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Allied Healthcare Group dated 8th November 2013. It announces the first sale and shipment of the CardioCel product into Europe, following regulatory approval (CE mark). The content focuses on product commercialization, market expansion, and future growth expectations. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is a corporate announcement about a business milestone and product launch rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general corporate announcement about a commercial event. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories.
2013-11-07 English
Change in substantial holding 2 pages 583.4KB
Regulatory Filings
2013-11-03 English
Appendix 3B - Options & Notice under Section 708A 15 pages 781.4KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard regulatory filing used to announce the allotment of new shares upon the exercise of options. It details the number of shares issued, exercise price, and compliance with ASX listing rules. The document is not a financial report, earnings release, or management discussion but a formal announcement of a capital change event (exercise of options and new share allotment). This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length is substantial and contains detailed information about the share issue, not just a brief notice or a report publication announcement. Therefore, the correct classification is SHA with high confidence.
2013-11-03 English
Allied awarded Industry's Emerging Company of the Year 3 pages 289.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 31 October 2013, detailing Allied Healthcare Group receiving an industry award for Emerging Company of the Year. It highlights the company's achievements over the past year, including revenue growth, product approvals, clinical trials, and grants. The content focuses on company progress, milestones, and strategic developments rather than financial statements or regulatory filings. There is no indication that this is a full annual report, interim report, earnings release, or any other formal financial filing. The document is a corporate announcement celebrating an award and summarizing company achievements, which fits best under the category of a general regulatory announcement or miscellaneous company update. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (9603 characters) and content do not suggest it is a report publication announcement or a detailed financial report.
2013-10-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.